312 related articles for article (PubMed ID: 29892039)
1. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
[TBL] [Abstract][Full Text] [Related]
2. FGF21 decreases food intake and body weight in obese Göttingen minipigs.
Christoffersen B; Straarup EM; Lykkegaard K; Fels JJ; Sass-Ørum K; Zhang X; Raun K; Andersen B
Diabetes Obes Metab; 2019 Mar; 21(3):592-600. PubMed ID: 30328263
[TBL] [Abstract][Full Text] [Related]
3. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
4. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates.
Thompson WC; Zhou Y; Talukdar S; Musante CJ
J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):411-25. PubMed ID: 27405817
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
Sarruf DA; Thaler JP; Morton GJ; German J; Fischer JD; Ogimoto K; Schwartz MW
Diabetes; 2010 Jul; 59(7):1817-24. PubMed ID: 20357365
[TBL] [Abstract][Full Text] [Related]
6. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
Véniant MM; Komorowski R; Chen P; Stanislaus S; Winters K; Hager T; Zhou L; Wada R; Hecht R; Xu J
Endocrinology; 2012 Sep; 153(9):4192-203. PubMed ID: 22798348
[TBL] [Abstract][Full Text] [Related]
7. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.
Talukdar S; Zhou Y; Li D; Rossulek M; Dong J; Somayaji V; Weng Y; Clark R; Lanba A; Owen BM; Brenner MB; Trimmer JK; Gropp KE; Chabot JR; Erion DM; Rolph TP; Goodwin B; Calle RA
Cell Metab; 2016 Mar; 23(3):427-40. PubMed ID: 26959184
[TBL] [Abstract][Full Text] [Related]
8. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys.
Blevins JE; Graham JL; Morton GJ; Bales KL; Schwartz MW; Baskin DG; Havel PJ
Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R431-8. PubMed ID: 25540103
[TBL] [Abstract][Full Text] [Related]
9. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
[TBL] [Abstract][Full Text] [Related]
10. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
Ramsey JJ; Colman RJ; Swick AG; Kemnitz JW
Am J Clin Nutr; 1998 Jul; 68(1):42-51. PubMed ID: 9665095
[TBL] [Abstract][Full Text] [Related]
11. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
[TBL] [Abstract][Full Text] [Related]
12. Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of Zucker obese rats.
Balada F; Sanchis D; Grasa MM; Virgili J; Estruch J; Fernández-López JA; Remesar X; Alemany M
Int J Obes Relat Metab Disord; 1997 Sep; 21(9):789-95. PubMed ID: 9376892
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
14. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
15. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
16. LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys.
Adams AC; Halstead CA; Hansen BC; Irizarry AR; Martin JA; Myers SR; Reynolds VL; Smith HW; Wroblewski VJ; Kharitonenkov A
PLoS One; 2013; 8(6):e65763. PubMed ID: 23823755
[TBL] [Abstract][Full Text] [Related]
17. The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
Makarova E; Kazantseva A; Dubinina A; Jakovleva T; Balybina N; Baranov K; Bazhan N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638898
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice.
O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
PLoS One; 2018; 13(8):e0202350. PubMed ID: 30157220
[TBL] [Abstract][Full Text] [Related]
19. Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice.
Camacho RC; Zafian PT; Achanfuo-Yeboah J; Manibusan A; Berger JP
Eur J Pharmacol; 2013 Sep; 715(1-3):41-5. PubMed ID: 23831019
[TBL] [Abstract][Full Text] [Related]
20. SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats.
Yokono M; Takasu T; Hayashizaki Y; Mitsuoka K; Kihara R; Muramatsu Y; Miyoshi S; Tahara A; Kurosaki E; Li Q; Tomiyama H; Sasamata M; Shibasaki M; Uchiyama Y
Eur J Pharmacol; 2014 Mar; 727():66-74. PubMed ID: 24486393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
